Safety of Very Low Low-Density Lipoprotein Cholesterol Levels With Alirocumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety of Very Low Low-Density Lipoprotein Cholesterol Levels With Alirocumab

Published:2017-02 Issue:5 Volume:69 Page:471-482
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Robinson Jennifer G.,Rosenson Robert S.,Farnier Michel,Chaudhari Umesh,Sasiela William J.,Merlet Laurence,Miller Kathryn,Kastelein John J.P.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials;Boekholdt;J Am Coll Cardiol,2014

2. Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy;Wiviott;J Am Coll Cardiol,2005

3. Safety profile of subjects treated to very low low-density lipoprotein cholesterol levels (<30 mg/dl) with rosuvastatin 20 mg daily (from JUPITER);Everett;Am J Cardiol,2014

4. Ezetimibe added to statin therapy after acute coronary syndromes;Cannon;N Engl J Med,2015

5. Efficacy and safety of alirocumab in reducing lipids and cardiovascular events;Robinson;N Engl J Med,2015

Cited by 176 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low LDL-C: Is It all Good News?;Current Atherosclerosis Reports;2024-09-10

2. PCSK9 inhibitor effectively alleviated cognitive dysfunction in a type 2 diabetes mellitus rat model;PeerJ;2024-08-14

3. Proprotein convertase subtilisin/kexin type 9 deficiency in extrahepatic tissues: emerging considerations;Frontiers in Pharmacology;2024-07-30

4. Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation;European Heart Journal - Cardiovascular Pharmacotherapy;2024-04-20

5. There are those who would like zero LDL cholesterol;European Heart Journal Supplements;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3